Paper33737844
Towards Eradication of Malaria: Is the WHO's RTS,S/AS01 Vaccination Effective Enough?
Arora N and 2 others. Risk Manag Healthc Policy, 2021. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Towards Eradication of Malaria: Is the WHO's RTS,S/AS01 Vaccination Effective Enough? Papers, record 33737844. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33737844
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21893544 | Vaccines against malaria. | Philos Trans R Soc Lond B Biol Sci | 2011 | https://conductscience.org/library/papers/21893544 | PubMed |
| 2 | 18165505 | Two decades of commitment to malaria vaccine development: GlaxoSmithKline Biologicals. | Am J Trop Med Hyg | 2007 | https://conductscience.org/library/papers/18165505 | PubMed |
| 3 | 27070151 | The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan. | PLoS Med | 2016 | https://conductscience.org/library/papers/27070151 | PubMed |
| 4 | 8988885 | A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. | N Engl J Med | 1997 | https://conductscience.org/library/papers/8988885 | PubMed |
| 5 | 32534628 | Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial. | Lancet | 2020 | https://conductscience.org/library/papers/32534628 | PubMed |
| 6 | 17190797 | Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17190797 | PubMed |
| 7 | 19569965 | Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19569965 | PubMed |
| 8 | 33298967 | Malaria vaccine research & innovation: the intersection of IA2030 and zero malaria. | NPJ Vaccines | 2020 | https://conductscience.org/library/papers/33298967 | PubMed |
| 9 | 31060446 | Malaria today: advances in management and control. | Trop Doct | 2019 | https://conductscience.org/library/papers/31060446 | PubMed |
| 10 | 27355532 | Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27355532 | PubMed |
| 11 | 25913272 | Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. | Lancet | 2015 | https://conductscience.org/library/papers/25913272 | PubMed |
| 12 | 20042088 | Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. | Malar J | 2009 | https://conductscience.org/library/papers/20042088 | PubMed |
| 13 | 26908756 | Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01. | J Infect Dis | 2016 | https://conductscience.org/library/papers/26908756 | PubMed |
| 14 | 17045367 | A review of human vaccine research and development: malaria. | Vaccine | 2007 | https://conductscience.org/library/papers/17045367 | PubMed |
| 15 | 23136909 | A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. | N Engl J Med | 2012 | https://conductscience.org/library/papers/23136909 | PubMed |
| 16 | 33421653 | Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development. | Infect Genet Evol | 2021 | https://conductscience.org/library/papers/33421653 | PubMed |
| 17 | 23454164 | Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. | Lancet Infect Dis | 2013 | https://conductscience.org/library/papers/23454164 | PubMed |
| 18 | 32566259 | Malaria vaccines since 2000: progress, priorities, products. | NPJ Vaccines | 2020 | https://conductscience.org/library/papers/32566259 | PubMed |
| 19 | 26488565 | Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26488565 | PubMed |
| 20 | 19064623 | Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. | N Engl J Med | 2008 | https://conductscience.org/library/papers/19064623 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41983137 | Poly(I:C) and R848 adjuvants elicit sizeable humoral immunity to liver stage malaria antigens. | Front Immunol | 2026 | https://conductscience.org/library/papers/41983137 | PubMed |
| 41779824 | Knowledge, attitudes and factors associated with the awareness of caregivers of under-five children regarding the malaria vaccine in the Tiko Health District, Cameroon: A community-based cross-sectional study. | PLOS Glob Public Health | 2026 | https://conductscience.org/library/papers/41779824 | PubMed |
| 40301403 | Unveiling mismatch of RTS S AS01 and R21 Matrix M malaria vaccines haplotype among Ethiopian Plasmodium falciparum clinical isolates. | Sci Rep | 2025 | https://conductscience.org/library/papers/40301403 | PubMed |
| 39975623 | Evasive mechanisms of human VSG and PfEMP1 antigens with link to Vaccine scenario: a review. | J Parasit Dis | 2025 | https://conductscience.org/library/papers/39975623 | PubMed |
| 39893367 | Controlled human malaria infection: overview and potential application in the evaluation of transmission-blocking interventions in malaria-endemic areas. | Malar J | 2025 | https://conductscience.org/library/papers/39893367 | PubMed |
| 39825389 | Integrating malaria vaccine and CRISPR/Cas9 gene drive: a comprehensive strategy for accelerated malaria eradication. | Malar J | 2025 | https://conductscience.org/library/papers/39825389 | PubMed |
| 39770302 | Contribution of Magnetic Resonance Imaging Studies to the Understanding of Cerebral Malaria Pathogenesis. | Pathogens | 2024 | https://conductscience.org/library/papers/39770302 | PubMed |
| 39525724 | Emerging public health strategies in malaria control: innovations and implications. | Ann Med Surg (Lond) | 2024 | https://conductscience.org/library/papers/39525724 | PubMed |
| 39189240 | Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax: Follow-Up Study. | Antibodies (Basel) | 2024 | https://conductscience.org/library/papers/39189240 | PubMed |
| 39145352 | An immunoinformatics approach for design and validation of multi-subunit vaccine against Plasmodium falciparum from essential hypothetical proteins. | J Parasit Dis | 2024 | https://conductscience.org/library/papers/39145352 | PubMed |
| 39085983 | A landscape review of malaria vaccine candidates in the pipeline. | Trop Dis Travel Med Vaccines | 2024 | https://conductscience.org/library/papers/39085983 | PubMed |
| 38874346 | Antimalarial activity of cecropin antimicrobial peptides derived from Anopheles mosquitoes. | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/38874346 | PubMed |
| 38716733 | Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans. | JCI Insight | 2024 | https://conductscience.org/library/papers/38716733 | PubMed |
| 38460299 | Evaluation of different types of adjuvants in a malaria transmission-blocking vaccine. | Int Immunopharmacol | 2024 | https://conductscience.org/library/papers/38460299 | PubMed |
| 38032502 | In-silico analysis of potent Mosquirix vaccine adjuvant leads. | J Genet Eng Biotechnol | 2023 | https://conductscience.org/library/papers/38032502 | PubMed |
| 37900033 | Mitigating the effects of climate change on human health with vaccines and vaccinations. | Front Public Health | 2023 | https://conductscience.org/library/papers/37900033 | PubMed |
| 37382251 | Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review. | Immun Inflamm Dis | 2023 | https://conductscience.org/library/papers/37382251 | PubMed |
| 37274361 | Malaria: An Overview. | Infect Drug Resist | 2023 | https://conductscience.org/library/papers/37274361 | PubMed |
| 37198702 | Malaria vaccines: the 60-year journey of hope and final success-lessons learned and future prospects. | Trop Med Health | 2023 | https://conductscience.org/library/papers/37198702 | PubMed |
| 37112704 | A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37112704 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CS | 1431 | PubTator's text mining | https://conductscience.org/library/genes/1431 | NCBI Gene |
| ENOSF1 | 55556 | PubTator's text mining | https://conductscience.org/library/genes/55556 | NCBI Gene |
| NANP | 140838 | PubTator's text mining | https://conductscience.org/library/genes/140838 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33737844
GET https://conductscience.org/api/papers/v1/33737844/references?page=2